The European Commission has allocated $2 million for studies of antibodies that will eradicate tumors by destroying the tumor's blood vessels. Britain's University of Birmingham and a biotech company in Utrecht, the Netherlands, received the European Industrial Doctorate grant, which sponsors academic and business partnerships.
Europe provides $2M for research of antibodies against tumors
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||